trending Market Intelligence /marketintelligence/en/news-insights/trending/-hgfjz_4URXP323ylbiMLQ2 content esgSubNav
In This List

Krynica Vitamin Q2 profit falls YOY


Expand Your Perspective: Intelligence


Next in Tech | Episode 66: Connected vehicles in transition


Gold - Geopolitical tensions and inflation remain key drivers


Lithium and Cobalt - Softer demand weighs on prices

Krynica Vitamin Q2 profit falls YOY

Krynica Vitamin S.A. said its normalized net income for the second quarter came to 25 groszy per share, a decline of 21.4% from 31 groszy per share in the prior-year period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 3.0 million zlotys, a decline of 15.2% from 3.6 million zlotys in the year-earlier period.

The normalized profit margin declined to 5.6% from 7.0% in the year-earlier period.

Total revenue grew 15.2% year over year to 58.4 million zlotys from 50.7 million zlotys, and total operating expenses climbed 19.9% from the prior-year period to 53.6 million zlotys from 44.7 million zlotys.

Reported net income decreased on an annual basis to 4.2 million zlotys, or 34 groszy per share, from 4.3 million zlotys, or 38 groszy per share.

As of Sept. 30, US$1 was equivalent to 3.83 zlotys.